Covered recipient · General Payments record
DOMINIQUE ZADRIMA
General Payments · PY2024
$377.77
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $377.77 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $183.76 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $42.90 | 2 |
| PFIZER INC. | $29.14 | 1 |
| EISAI INC. | $28.43 | 1 |
| Lundbeck LLC | $27.19 | 1 |
| SK Life Science, Inc. | $26.35 | 1 |
| Lilly USA, LLC | $24.44 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.56 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $377.77 | 15 |
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.81 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108456050 | CMS |
| ABBVIE INC. | $19.58 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108456052 | CMS |
| ABBVIE INC. | $26.76 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108456054 | CMS |
| ABBVIE INC. | $28.46 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108456056 | CMS |
| ABBVIE INC. | $28.80 | 10/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108456058 | CMS |
| ABBVIE INC. | $27.62 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108456060 | CMS |
| ABBVIE INC. | $27.73 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108456062 | CMS |
| Eisai Inc. | $28.43 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110800145 | CMS |
| Lilly USA, LLC | $24.44 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135549439 | CMS |
| Lundbeck LLC | $27.19 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146110548 | CMS |
| Novartis Pharmaceuticals Corporation | $16.55 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087440572 | CMS |
| Novartis Pharmaceuticals Corporation | $26.35 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087440580 | CMS |
| PFIZER INC. | $29.14 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131980237 | CMS |
| SK Life Science, Inc. | $26.35 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154136638 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.56 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137848362 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.